Private equity firm, Naxicap Partners has closed the acquisition of a majority stake in Groupe 3R (Réseau Radiologique Romand), a Swiss radiological network created by Dr. Dominique Fournier. The advisors Python advised Naxicap Partners
Swiss Nuclides, a developer of novel radionuclide Pet tracers for the precision diagnostics, has closed the first tranche of its series A financing round, raising CHF 2.6 million from private investors. Vischer has been acting as
Walder Wyss has acted as legal counsel to Swisscanto Invest by Zürcher Kantonalbank in connection with the series B financing round of Sulzer & Schmid Laboratories, an independent Swiss technology company of next-generation technology
Ubitec, a developer of software solutions for digitization, was taken over by Swiss IT services provider Umb Solution. Umb is strengthening its range of services for the digitization of applications and processes by adding ubitec’
Bomi Italia, an Italian multinational active in the logistics sector and in the management of high-tech products for the protection of health, acquired Vercesi Group, a historic company specialized in international transport at controlled temperatures
Private investment company Drs Investment sells 100 per cent of the shares in the Swiss software company Xelog to Prologistik Holding. The acquisition of Xelog, the Swiss logistics software specialist, is part of Prologistik’s strategy
Advestra advises Kempen & Co. as the sole global coordinator and sole bookrunner on the placement of CHF 180 million unsecured, subordinated mandatory convertible bonds issued by Peach Property Group. On this transaction, Advestra team included
Transocean entered into an equity distribution agreement with Jefferies. Pursuant to the terms of the agreement, Transocean may offer and sell its shares, par value CHF 0.10 per share, from time to time through Jefferies, as
Molecular Partners, a clinical-stage biotech company, announced the pricing of its Initial Public Offering of 3,000,000 American Depositary Shares (ADS) in the United States at a public offering price of USD 21.25 per ADS, for total gross
Gyrus Capital, an investment firm dedicated to investments in the healthcare and sustainability sectors, has agreed to acquire PwC Italia’s consulting business focused on Italian public administration and public healthcare systems. The business, which
